Richard Jimenez, MD
Rheumatology · Bothell, WANPI 1366484040
Payments from drug & device makers
Across 981 payments — averaging $360.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$151K
- AbbVie$91K
- Amgen$58K
- Bristol Myers Squibb$18K
- Johnson & Johnson$10K
- Mallinckrodt Enterprises LLC$9K
- plus $17K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 86 | $150,666 |
| AbbVie | 225 | $90,958 |
| Amgen(2 entities) | 200 | $57,985 |
| Bristol Myers Squibb | 38 | $18,147 |
| Johnson & Johnson | 111 | $9,516 |
| Mallinckrodt Enterprises LLC | 17 | $9,437 |
| Kyowa Kirin, Inc. | 9 | $6,629 |
| AstraZeneca(2 entities) | 36 | $3,184 |
| Mallinckrodt Hospital Products Inc. | 3 | $1,738 |
| UCB, Inc. | 29 | $884 |
| E.r. Squibb & Sons, L.L.C. | 42 | $600 |
| GSK | 27 | $597 |
| Lilly USA, LLC | 25 | $583 |
| Sobi, Inc | 18 | $430 |
| Pfizer | 32 | $418 |
| Radius Health, Inc. | 18 | $287 |
| Genentech USA, Inc. | 16 | $264 |
| Boehringer Ingelheim | 8 | $192 |
| Sanofi | 6 | $178 |
| Aurinia Pharma U.S., Inc. | 5 | $110 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $104 |
| Hikma Pharmaceuticals USA | 5 | $74 |
| ANI Pharmaceuticals, Inc. | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Sandoz | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $28 |
| Sentynl Therapeutics, Inc. | 2 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $19 |
| Gilead | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Bioventus LLC | 1 | $13 |
| Janssen Scientific Affairs, LLC | 1 | $9 |
How this compares
$353,426 in reported general payments places this provider in the 90th percentile of 157 rheumatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Bothell
- Jeff PetersonBothell$3M
- Andrew SolomonBothell$47K
- Philip MeaseSeattle$5.1M
- Stanford PengSeattle$3.5M
- Eric MuellerSpokane$3M
- Jane BucknerSeattle$1.8M
- Kwang Hoon HanSeattle$1.5M
- Arinola DadaBellevue$1.3M
- Howard KenneySpokane$1.3M
- Sean LasalleSpokane$982K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.